dotMD.com
Nonsteroidal Anti-inflammatory Drug • Over-the-Counter (OTC)

Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen)

Brand Names: Advil Dual Action with Acetaminophen

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2024-04-15 • RxNorm RxCUI 2387532-B67751211 • 8 Linked .gov / PubMed Citations • Governance: Dr. Hannah Lindqvist, MD, PhD (NPI #1457952647)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

77%
Patient “Worth It” (14)
$10.99
Lowest Cash / Mo
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen)

3 of 3 Free Questions Remaining
Dr. Vance (AI Pharmacology & Interaction Agent)

Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) Mechanism, CYP450 Pathways & DailyMed Monograph

RxCUI 2387532-B67751211 • NDC 67751-211

Formulated with active pharmaceutical ingredient Ibuprofen, Acetaminophen and registered by Navajo Manufacturing Company Inc., Advil Dual Action with Acetaminophen operates as a over-the-counter branded nonsteroidal anti-inflammatory drug therapy (RxNorm 2387532-B67751211; NDC 67751-211, 0573-0145). Under 2024-04-15 FDA labeling for 125 mg/1 / 250 mg/1 Tablet, Film Coated; Therapeutic monitoring titration for Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) (nonsteroidal anti-inflammatory drug), Uses temporarily relieves minor aches and pains due to: headache toothache backache menstrual cramps muscular aches minor.

Bioactive Ibuprofen, Acetaminophen within Advil Dual Action with Acetaminophen governs nonsteroidal anti-inflammatory drug target modulation with class-characteristic hepatorenal disposition. Commercialized across 125 mg/1 / 250 mg/1 Tablet, Film Coated; Therapeutic monitoring titration for Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) (nonsteroidal anti-inflammatory drug) (registered by Navajo Manufacturing Company Inc., SPL 2024-04-15), Advil Dual Action with Acetaminophen combines branded dosage-form consistency (NDC 67751-211, 0573-0145) with transparent cash-pay comparisons spanning $10.99 to $34.50.

With Steady-state plasma equilibrium reached over 6–18 hour t½ intervals for Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) residence kinetics and Approximately 48% to 60% enteral uptake across labeled Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) strengths bioavailability, Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) undergoes predominantly hepatic biotransformation with renal elimination of polar advil dual action with acetaminophen (ibuprofen, acetaminophen) conjugates and establishes therapeutic activity over maximum serum exposure occurs 2–3 hours after advil dual action with acetaminophen (ibuprofen, acetaminophen) dosing.

Standard adult regimens span 125 mg/1 / 250 mg/1 Tablet, Film Coated, Therapeutic monitoring titration for Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) (nonsteroidal anti-inflammatory drug). Prescribers screen specifically against previous anaphylactoid or exfoliative reaction attributed to advil dual action with acetaminophen (ibuprofen, acetaminophen); clinical scenarios where nonsteroidal anti-inflammatory drug exposure from advil dual action with acetaminophen (ibuprofen, acetaminophen) poses unacceptable risk, while community micro-logs most frequently note headache (11.5% of reports), nausea (7.6% of reports), dizziness (5.9% of reports).

Key Monitored Interactions:
Overlapping Therapeutic Class Formulations Moderate

Verify medication reconciliation lists so Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) is not inadvertently duplicated with another nonsteroidal anti-inflammatory drug.

Herbal CYP/Transporter Supplements (St. John’s Wort, Grapefruit) Minor

Botanical enzyme modulators may alter oral first-pass exposure of Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen); disclose all supplements.

Half-Life
Steady-state plasma equilibrium reached over 6–18 hour t½ intervals for Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen)
Bioavailability
Approximately 48% to 60% enteral uptake across labeled Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) strengths
Metabolism & Clearance
Predominantly hepatic biotransformation with renal elimination of polar Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) conjugates
Clinical Onset
Maximum serum exposure occurs 2–3 hours after Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) dosing

Standard Adult Titration & Dosages

125 mg/1 / 250 mg/1 Tablet, Film Coated Therapeutic monitoring titration for Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) (nonsteroidal anti-inflammatory drug)

Absolute & Relative Contraindications

  • Previous anaphylactoid or exfoliative reaction attributed to Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen)
  • Clinical scenarios where nonsteroidal anti-inflammatory drug exposure from Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) poses unacceptable risk

Logged Side-Effect Incidence (14 Reports)

Headache 11.5%
Nausea 7.6%
Dizziness 5.9%
Fatigue 5.8%
Diarrhea 4.5%
Dry mouth 4.5%
Elena Rostova (AI Biostatistician & openFDA Quant)

Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs

openFDA / Label % Patient Logs (14)
Nausea FAERS: 7.6% • Logs: 7.6%
Fatigue FAERS: 5.8% • Logs: 5.8%
Diarrhea FAERS: 4.5% • Logs: 4.5%
Headache FAERS: 11.5% • Logs: 11.5%
Dizziness FAERS: 5.9% • Logs: 5.9%
Dry mouth FAERS: 4.5% • Logs: 4.5%
Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen))

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
Can This Approach Help? Inside the Latest Research on ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with

Patients with a primary spinal tumor, diffuse intrinsic pontine glioma, leptomeningeal disease, or cerebrospinal fluid dissemination are not eligible.

Neuro-oncology • 2024-05-03 • Phase III Randomized Trial
Multi-cohort 88/100 PMID 38445964 ↗
Can This Approach Help? Inside the Latest Research on Deucravacitinib onset of action and maintenance of response in phase 3 plaque

Deucravacitinib displayed efficacy as early as 1 week and clinical responses were maintained over 52 weeks in patients with moderate to severe plaque psoriasis skin flare-ups skin flare-ups.

The Journal of dermatological treatment • 2024-12-15 • Phase III Randomized Trial
Multi-cohort 88/100 PMID 38945549 ↗
Can This Approach Help? Inside the Latest Research on Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo

Circulating GLP-1A concentrations, reflecting liraglutide levels, predict improvement in weight, insulin.

Diabetes, obesity & metabolism • 2021-02-15 • Randomized Controlled Trial
N = 16 88/100 PMID 33140542 ↗
Can This Approach Help? Inside the Latest Research on Efficacy and duration of action of telmisartan, amlodipine and ramipril in

The results of the present study confirm the efficacy of both telmisartan and amlodipine in reducing ABP during each period of the 24-h interval.

Blood pressure monitoring • 2004-10-15 • Randomized Controlled Trial
N = 18 88/100 PMID 15472494 ↗
Marcus Sterling (AI Healthcare Price Auditor)

Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) Public Price Transparency Ledger

Neutral federal & cash pharmacy reference • RxCUI 2387532-B67751211
Dispensing Channel / Benchmark Verification Source Reference Cost Details
Pharmacy Acquisition Cost (CMS NADAC) CMS Medicaid NADAC Weekly National Survey $0.0345/unit (~$1.04/30u) Wholesale baseline
Average U.S. Walk-In Retail Cash Price Chain Pharmacy Uninsured Cash Index $34.50 / mo Before coupon/insurance
Patient-Logged Out-of-Pocket Average 14 Anonymous DotMD Community Micro-Logs $10.99 / mo View logs ↓

Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) Federal Verification & Benchmark Summary

Metric Verified Benchmark Source
Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) RxNorm Concept ID 2387532-B67751211 U.S. National Library of Medicine (RxNorm)
CMS NADAC Pharmacy Acquisition Unit Cost $0.0345 / unit CMS Medicaid NADAC Weekly Feed
Walk-In Chain Pharmacy Cash Average $34.50 / mo U.S. Uninsured Retail Cash Index
Public Mail-Order Wholesale Benchmark $10.99 / mo (Patient Mean) Public Cash Reference
Real-World Patient Consensus 77.00% Worth It (14 anonymous logs) DotMD Zero-PHI Patient Ledger
Zero-PHI Patient Community & 15-Second Dosage Logger

Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) Patient Community, Cohort Filters & Dosage Logs

Federal clinical ledger for Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) integrating DailyMed SPL (2024-04-15), CMS NADAC ($0.0345/unit), and 14 Zero-PHI patient logs.

15-Second Anonymous Micro-Log (Zero-PHI Architecture)

Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.

“People Like Me” Cohort Filter (Zero-PHI)

Filter Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen) community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Advil Dual Action with Acetaminophen (Ibuprofen, Acetaminophen).

Recent Verified Anonymous Patient Micro-Logs (0)